EditorialCreativeSportKollektionenVideos
Preise
0Anmelden

Visuelle Inhalte für Profis.
800 Mio.+ Bilder und Videos.

Content-Hub

  • Aktuelle Ereignisse
  • Bilder des Jahres
  • Sport
  • Editorial
  • Creative
  • Kollektionen
  • Videos

Angebote

  • Preise & Pakete
  • Aktionen
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Bildrecherche
  • Auftragsfotografie
  • API & FTP Push
  • my-picturemaxx
  • Partner werden

Unternehmen

  • Über IMAGO
  • Karriere
  • News

Hilfe-Center

  • FAQ
  • Kontakt
ImpressumNutzungsbedingungenLizenzinformationenDatenschutzDatenschutzeinstellungen
© 2026 IMAGO
CEPICBAPLABVPA
  5. Coronavirus in Tschechien, Klinik Pk in Prag zur Behandlung mit dem Medikament Remdesivir

Coronavirus in Tschechien, Klinik Pk in Prag zur Behandlung mit dem Medikament Remdesivir

27.03.2020

Die folgenden Fotos wurden von der IMAGO Bildredaktion zu diesem Thema für Sie ausgewählt. Für weitere Bilder nutzen Sie bitte die Suchfunktion.

Bilder in dieser Kollektion

  • Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481601 kru 7 K

    Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481601 kru 7 K

  • Doctor Martin Balik of the General Teaching Hospital in Prague speaks during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481501 kru 3

    Doctor Martin Balik of the General Teaching Hospital in Prague speaks during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481501 kru 3

  • Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481101 kru 6

    Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270481101 kru 6

  • Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270480601 kru 5

    Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270480601 kru 5

  • Director of the General Teaching Hospital in Prague David Feltl speaks during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270480001 kru 4

    Director of the General Teaching Hospital in Prague David Feltl speaks during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270480001 kru 4

  • Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270479601 kru 2

    Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270479601 kru 2

  • Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270470801 kru 1

    Doctor Martin Balik, left, and director of the General Teaching Hospital in Prague David Feltl, right, speak during a press conference on coronavirus treatment, on March 27, 2020, in Prague, Czech Republic. The condition of a Czech COVID-19 patient has markedly improved after the U.S. remdesivir experimental medicine was administered to him for three days. (CTKxPhoto MichalxKrumphanzl) CTKPhotoP202003270470801 kru 1

Kollektionen
Events